LRRTM1 antibody
Principal name
LRRTM1 antibody
Alternative names for LRRTM1 antibody
Leucine-rich repeat transmembrane neuronal protein 1
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Paraffin Sections (P), Enzyme Immunoassay (E)
Background of LRRTM1 antibody
- Kit Component:
- - KN309516G1, Lrrtm1 gRNA vector 1 in pCas-Guide vector
- KN309516G2, Lrrtm1 gRNA vector 2 in pCas-Guide vector
- KN309516D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Francks, C. Laterality 14(1):11-16(2009)
Crow, T.J., et al. Laterality 14(1):3-10(2009)
McManus, C., et al. Laterality 14(1):1-2(2009)
Human Placenta; WB Suggested Anti-LRRTM1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:12500. Positive Control: Human Placenta; LRRTM1 antibody - middle region (ARP55787_P050) in Human Placenta cells using Western Blot
Human Muscle; WB Suggested Anti-LRRTM1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human Muscle; LRRTM1 antibody - middle region (ARP55788_P050) in Human Muscle cells using Western Blot
Western blot analysis of LRRTM1 in mouse brain tissue lysate with LRRTM1 antibody at 1 μg/ml in (A) the absence and (B) the presence of blocking peptide.
Immunohistochemistry analysis in formalin fixed and paraffin embedded brain tissue reacted with LRRTM1 Antibody (Center) Cat.-No AP52549PU-N, which was peroxidase conjugated to the secondary antibody and followed by DAB staining.
Western blot analysis of LRRTM1 Antibody (Center) Cat.-No AP52549PU-N in mouse brain tissue lysates (35ug/lane). LRRTM1 (arrow) was detected using the purified Pab.
Immunohistochemical staining of paraffin-embedded Human lymphoma tissue using anti-LRRTM1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min, TA805446)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LRRTM1 (RC207949, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LRRTM1.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LRRTM1 (RC207949, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LRRTM1.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LRRTM1 (RC207949, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LRRTM1.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human liver tissue using anti-LRRTM1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min, TA805611)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-LRRTM1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min, TA805611)
Immunohistochemical staining of paraffin-embedded Human lymphoma tissue using anti-LRRTM1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min, TA805611)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LRRTM1 (RC207949, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LRRTM1.
Western blot analysis of LRRTM1 in mouse brain tissue lysate with LRRTM1 antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.
Immunohistochemistry of LRRTM1 in human brain tissue with LRRTM1 antibody at 5 ug/mL.
Immunofluorescence of LRRTM1 in human brain tissue with LRRTM1 antibody at 20 ug/mL.
WB Suggested Anti-LRRTM1 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:12500; Positive Control: Human Placenta
WB Suggested Anti-LRRTM1 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: Human Muscle
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA805611 | LRRTM1 antibody |
||||||
| LRRTM1 mouse monoclonal antibody, clone OTI5H9 (formerly 5H9) | |||||||
 |
Mouse | IgG2a | OTI5H9 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +3 additional images |
Highly validated antibody!
|
||||||
| TA320176 | LRRTM1 (C-term) antibody |
||||||
| Rabbit Polyclonal LRRTM1 Antibody | |||||||
 |
Rabbit | Aff - Purified | Hu, Ms, Rt | E, WB |
0.1 mg /
€415.00
|
||
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|||||||
| TA805446 | LRRTM1 antibody |
||||||
| LRRTM1 mouse monoclonal antibody, clone OTI1C5 (formerly 1C5) | |||||||
 |
Mouse | IgG2a | OTI1C5 | Purified | Hu | P |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA805486 | LRRTM1 antibody |
||||||
| LRRTM1 mouse monoclonal antibody, clone OTI2C6 (formerly 2C6) | |||||||
 |
Mouse | IgG2b | OTI2C6 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA805501 | LRRTM1 antibody |
||||||
| LRRTM1 mouse monoclonal antibody, clone OTI1C9 (formerly 1C9) | |||||||
 |
Mouse | IgG2a | OTI1C9 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA805610 | LRRTM1 antibody |
||||||
| LRRTM1 mouse monoclonal antibody, clone OTI5C3 (formerly 5C3) | |||||||
 |
Mouse | IgG2a | OTI5C3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| AP52549PU-N | LRRTM1 (Center) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu, Ms | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| +1 additional image |
|||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY405855 | LRRTM1 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |